Cannabis, or marijuana, is its official name. Cannabis sativa leaves and flowers produce it. Marijuana possession is prohibited in the US and many other nations. Marijuana is a Schedule 1 drug with a high abuse potential and no medicinal purpose, according to the FDA. Many studies have shown that some marijuana compounds can treat fatal conditions like cancer and AIDS. Medical marijuana use sparked a heated debate. Marijuana and Medicine: Evaluating the Scientific Base, the 1999 IOM report, resolved this debate. The report was detailed but ambiguous. Opponents of medical marijuana typically quote the report. The report clarified many topics but did not resolve the debate.
Let's examine the medicinal marijuana legalization arguments.
(1) Marijuana is a natural herb used as medicine from South America to Asia for millennia. In this age of all-natural and organic health buzzwords, marijuana may be more enticing and safer than synthetic pharmaceuticals.
Marijuana is therapeutic. According to the IOM report, Glo Carts cannabis can be used to relieve pain. THC, a marijuana component, relieves chronic cancer pain in certain trials. Acute pain studies, such as surgery and trauma, are inconclusive. Certain marijuana components have antiemetic qualities and can reduce nausea and vomiting, which are major adverse effects of cancer chemotherapy and radiation therapy. The IOM report summarizes these research. Researchers believe cannabis may treat neurological illnesses like multiple sclerosis. Some marijuana chemicals are medicinal. CBD, a significant component of marijuana, is antipsychotic, anticancer, and antioxidant. Some cannabinoids inhibit excessive intraocular pressure (IOP), a major risk factor for glaucoma. Marinol, an antiemetic used to treat cancer chemotherapy-induced nausea and vomiting, contains active components from marijuana but was synthesized in the lab. Dronabinol—a synthetic delta-9-tetrahydrocannabinol—is its active component (THC).
The US-based Marijuana Policy Project (MPP) supports medical marijuana. Numerous medical associations have supported. In its 2008 position paper, the American College of Physicians suggested reassessing marijuana's Schedule I status. ACP strongly supports medicinal marijuana research and exemption from federal criminal prosecution, civil liability, and professional sanctions for physicians who prescribe or administer medical marijuana in line with state law. Medical marijuana users protected from criminal or civil consequences under state law.
(4) If they can do it, Glo Extracts why not us? another plus. Canada, Belgium, Austria, the Netherlands, the UK, Spain, Israel, and Finland have authorized medical marijuana under prescription. States states allow exemptions.
Now, medical marijuana's detractors.
(1) No safety or efficacy data. Drug regulation prioritizes safety. Marijuana and its components must be proven safe. Efficacy is secondary. Medical marijuana should have more advantages than hazards. Medical marijuana may not be approved unless it is safer and more effective than present medications. Robert J. Meyer of the Department of Health and Human Services said that having access to a drug or medical treatment without knowing how to utilize it or if it works is useless. Access alone does not help patients.
(2) Unknown chemicals. Only herbal medical marijuana is inexpensive and accessible. Marijuana is a botanical. Nevertheless, unpurified botanical products have lot-to-lot consistency, dosage determination, potency, shelf-life, and toxicity issues. Cannabinoids and their synthetic derivatives are marijuana's medical future, according to the IOM assessment. To thoroughly describe marijuana's components would take too much time and money, making its therapies prohibitively expensive. No pharmaceutical business is investing in isolating more medicinal components from marijuana.
Abuse risk. Cannabis is addicting. Marijuana may not be as addictive as cocaine, but it may be abused. The IOM report summarizes several studies showing this.
Unsafe delivery. Marijuana is usually smoked. Health authorities will never allow this distribution method given current anti-smoking laws. Vaporizers, nebulizers, and inhalers are being tested for reliability and safety.
(5) Relief, Glo Cartridge not cure. Marijuana merely treats illness symptoms. It doesn't heal these diseases. There are drugs that function as well or better than marijuana for certain symptoms without the negative effects or misuse risk.
Scientific evidence from the 1999 IOM report could not settle the medical marijuana dispute. The report discouraged smoking marijuana but supported medical inhalation or vaporization. The report also advised compassionate medical marijuana use. It also recommended financing marijuana safety and efficacy studies.
What prevents IOM report questions from being answered? Health authorities appear uninterested in another review. Data on the dangers of smoking marijuana is few and biased. Synthetic cannabis efficacy data dominates (e.g. THC). Data discrepancies make risk-benefit analysis harder.
Due to funding and laws, marijuana clinical trials are rare. Few pharmaceutical companies explore cannabinoids due of legal issues. Many organisations favor and oppose medical marijuana, but its definition is unclear. Does it include synthetic cannabinoids like THC and derivatives or just marijuana? Synthetic cannabinoids like Marinol are pricey, so people use marijuana instead. Conspiracies about the pharmaceutical sector and regulators cloud the problem.
Finally, more extensive and comparative scientific study is needed to settle the medicinal marijuana controversy. IOM report updates are needed soon.
0 kommentar(er)
